CCL Industries Inc.

Second-quarter 2025 sales were $1.9 billion, up 4.8% year over year, with 2% organic growth, 1% acquisition-related growth, and a 1.8% FX tailwind. Operating income was $322.1 million versus $303.5 million in Q2 2024; consolidated EBITDA increased 6% excluding FX. Net earnings were $213.1 million versus $279.5 million last year, with the prior-year quarter including a noncash $78.1 million revaluation gain. Adjusted basic EPS was $1.22, up 8% from $1.13, and free cash flow from operations was $226 million versus $118.8 million. For the first half, sales, operating income, and net income increased 6.7%, 9.1%, and 6.9%, respectively, excluding the revaluation gain. Guidance/comments: management expects 2025 capex of around $485 million; CCL segment order backlog is solid into Q3; Avery is expected to improve sequentially but August replenishment is a risk; Checkpoint ALS should pick up seasonally; Innovia should still post gains next quarter; and FX is a modest tailwind and may be neutral.

Geoff Martin emphasized that the quarter was driven by a mix of stronger operational performance and selective share gains, especially in CCL’s home and personal care, electronics/design, and some healthcare-related areas. He said the company is not changing its investment plans despite the tariff backdrop, and noted that the German film plant ramp will take several quarters, with material revenues expected in 2026. His tone was confident but measured: he repeatedly pointed to supply-chain disruption and tariffs as real near-term issues, while still expecting normalization and continued growth in areas like RFID and Innovia.

Sean Washchuk said Q2 operating income improved to $322.1 million and adjusted EPS rose 8% to $1.22, with the increase driven mainly by better operating income, FX, and lower finance costs. Net finance expense fell to $17.3 million from $18.6 million, the effective tax rate was 25.3% versus 18.8% a year ago, and free cash flow from operations improved to $226 million from $118.8 million. He also highlighted a strong balance sheet: net debt was $1.63 billion, leverage was about 1.04x, cash on hand was $963 million, and undrawn credit capacity was USD 0.8 billion. Shareholder returns remained active, with about 1.3 million shares repurchased for $100 million in the quarter and $312.1 million returned year-to-date including dividends.

Analysts focused on CCL segment margins, RFID growth, Avery’s back-to-school season, tariff impacts, and capital allocation. Management said CCL margin strength came mainly from a better-performing electronics business and strong HPC results; RFID slowed because apparel customers are reworking sourcing plans due to tariffs, and Geoff said the industry should return to double-digit growth once that disruption normalizes. On Avery, he said July was modestly down in revenue but August replenishment is the key watchpoint, and he did not expect to recover all of June’s decline. On buybacks and capital allocation, he suggested continued repurchases are likely if leverage stays where it is.